Mr. Chair, I want to thank the member for Burnaby—New Westminster for his speech. I do want to correct him, though. The resources are available. Actually, there is more money available than the take-up for research.
With that, I would like to ask him a question with regard to the research in his own community. According to UBC's MRI Research Centre, in order to determine whether CCSVI is beneficial, treated patients would need to be followed over time. In addition to proving that the treatment is safe, there are important questions that need to be asked. First, does the treatment improve symptoms such as fatigue in memory and how long does it last? Second, does the treatment stop MS over time? Third, how does the treatment of CCSVI affect iron deposits in the brain?
A treatment for CCSVI requires vigorous testing and research to prove it is safe and beneficial for Canadians suffering with MS.
I would ask the member, does he think that this is logical, or does the member disagree with the advice from UBC's MRI Research Centre?